297 related articles for article (PubMed ID: 18771727)
1. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C
Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
[TBL] [Abstract][Full Text] [Related]
2. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
[TBL] [Abstract][Full Text] [Related]
3. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
[TBL] [Abstract][Full Text] [Related]
4. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion.
Krause J; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2009 Jan; 71(1):138-44. PubMed ID: 18805483
[TBL] [Abstract][Full Text] [Related]
5. Alternative extrusion-spheronization aids.
Jain SP; Singh PP; Amin PD
Drug Dev Ind Pharm; 2010 Nov; 36(11):1364-76. PubMed ID: 20521907
[TBL] [Abstract][Full Text] [Related]
6. Approaches to developing fast release pellets via wet extrusion-spheronization.
Xia Y; Shi CY; Fang JG; Wang WQ
Pharm Dev Technol; 2018 Jun; 23(5):432-441. PubMed ID: 27882815
[TBL] [Abstract][Full Text] [Related]
7. Extrusion-spheronisation of microcrystalline cellulose pastes using a non-aqueous liquid binder.
Mascia S; Seiler C; Fitzpatrick S; Wilson DI
Int J Pharm; 2010 Apr; 389(1-2):1-9. PubMed ID: 20123008
[TBL] [Abstract][Full Text] [Related]
8. Quantification of mass transfer during spheronisation.
Koester M; Thommes M
AAPS PharmSciTech; 2012 Jun; 13(2):493-7. PubMed ID: 22415640
[TBL] [Abstract][Full Text] [Related]
9. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
Serratoni M; Newton M; Booth S; Clarke A
Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
[TBL] [Abstract][Full Text] [Related]
10. The use of partially hydrolysed polyvinyl alcohol for the production of high drug-loaded sustained release pellets via extrusion-spheronisation and coating: In vitro and in vivo evaluation.
Verstraete G; De Jaeghere W; Vercruysse J; Grymonpré W; Vanhoorne V; Stauffer F; De Beer T; Bezuijen A; Remon JP; Vervaet C
Int J Pharm; 2017 Jan; 517(1-2):88-95. PubMed ID: 27919698
[TBL] [Abstract][Full Text] [Related]
11. Development of starch-based pellets via extrusion/spheronisation.
Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467
[TBL] [Abstract][Full Text] [Related]
12. Influence of MCC II fraction and storage conditions on pellet properties.
Krueger C; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
[TBL] [Abstract][Full Text] [Related]
13. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
Liew CV; Gu L; Soh JL; Heng PW
Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
[TBL] [Abstract][Full Text] [Related]
14. Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronisation.
Tho I; Sande SA; Kleinebudde P
Eur J Pharm Biopharm; 2003 Nov; 56(3):371-80. PubMed ID: 14602179
[TBL] [Abstract][Full Text] [Related]
15. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
16. Supramolecular elucidation of the quality attributes of microcrystalline cellulose and isomalt composite pellet cores.
Antal I; Kállai N; Luhn O; Bernard J; Nagy ZK; Szabó B; Klebovich I; Zelkó R
J Pharm Biomed Anal; 2013 Oct; 84():124-8. PubMed ID: 23827942
[TBL] [Abstract][Full Text] [Related]
17. Drug release from reservoir pellets compacted with some excipients of different physical properties.
Tunón A; Börjesson E; Frenning G; Alderborn G
Eur J Pharm Sci; 2003 Dec; 20(4-5):469-79. PubMed ID: 14659491
[TBL] [Abstract][Full Text] [Related]
18. A comparison of screen and ram extrusion-spheronisation of simple pharmaceutical pastes based on microcrystalline cellulose.
Zhang M; Wilson DI; Ward R; Seiler C; Rough SL
Int J Pharm; 2013 Nov; 456(2):489-98. PubMed ID: 23999221
[TBL] [Abstract][Full Text] [Related]
19. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation.
Bornhöft M; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2005 Jan; 59(1):127-31. PubMed ID: 15567309
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical properties of granulating liquids and their influence on microcrystalline cellulose pellets obtained by extrusion-spheronisation technology.
Dreu R; Sirca J; Pintye-Hodi K; Burjan T; Planinsek O; Srcic S
Int J Pharm; 2005 Mar; 291(1-2):99-111. PubMed ID: 15707736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
